Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

Yang, J., Ambade, A. S., Nies, M., Griffiths, M., Damico, R., Vaidya, D., Brandal, S., Pauciulo, M. W., Lutz, K. A., Coleman, A. W., Nichols, W. C., Austin, E. D., Ivy, D., Hassoun, P. M., & Everett, A. D. (2022). Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival. Pulmonary Circulation, 12(1). Portico. https://doi.org/10.1002/pul2.12007
Authors:
Jun Yang
Anjira S Ambade
Melanie Nies
Megan Griffiths
Rachel Damico
Dhananjay Vaidya
Stephanie Brandal
Michael W Pauciulo
Katie A Lutz
Anna W Coleman
William C Nichols
Eric D Austin
Dunbar Ivy
Paul M Hassoun
Allen D Everett
Affiliated Authors:
Megan Griffiths
Author Keywords:
biomarker
hdgf
pah
vascular remodeling
Publication Type:
Article
Unique ID:
10.1002/pul2.12007
PMID:
Publication Date:
Data Source:
PubMed

Record Created: